Author

J. C. Becker

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Assay:scRNA-seq· 1 Approach:statistical model· 1

Frequent Co-Authors

K. Horny· 2 shared A. Paschen· 1 shared A. Roesch· 1 shared A. Sechi· 1 shared A. Zebisch· 1 shared B. Shannan· 1 shared C. Krepler· 1 shared C. Sproll· 1 shared

Activity by Year

2020-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 23 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

K. Horny

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Mesenchymal-epithelial transition in lymph node metastases of oral squamous cell carcinoma is accompanied by ZEB1 expression

K. Horny, C. Sproll, L. Peiffer, F. Furtmann, P. Gerhardt, J. Gravemeyer, N. H. Stoecklein, I. Spassova, J. C. Becker

This study identifies ZEB1 activity during mesenchymal-epithelial transition in lymph node metastases of oral squamous cell carcinoma, revealing partial MET states and their role in metastasis.

Journal of Translational Medicine · Apr 19, 2023Peer-reviewedCancer Biology

Persister state-directed transitioning and vulnerability in melanoma

H. Chauvistre, B. Shannan, S. M. Daignault, R. J. Ju, D. Picard, S. Egetemaier, R. Varaljai, A. Sechi, F. Kaschani, O. Keminer, S. J. Stehbens, Q. Liu, X. Yin, K. Jeyakumar, F. C. E. Vogel, , A. Roesch

This study identifies a compound that induces a persister state in melanoma cells, promoting differentiation and sensitizing them to a prodrug, offering a dual-target strategy for treatment.

bioRxiv · Apr 1, 2020Cancer Biology

Highly expressed miR-375 is not an intracellular oncogene in Merkel cell polyomavirus-associated Merkel cell carcinoma

K. Fan, A. Zebisch, K. Horny, D. Schrama, J. C. Becker

The paper knocks down miR-375 in MCC cell lines and finds no significant changes in viability, morphology, or oncogenic pathways, suggesting miR-375 is not an intracellular oncogene in MCC.

bioRxiv · Feb 18, 2020Cancer Biology